Business
Presentation at RSNA 2017
Presentation at RSNA 2017.
About this update from Feedback Plc
[{"type":"text","content":"\n \nRNS Number : 1585X Feedback PLC 22 November 2017 \n\nPresentation at RSNA 2017\n \nCambridge, UK - 22 November 2017: Feedback plc (\"Feedback\" or the \"Company\") (AIM: FDBK), the specialist medical imaging technology company, announces that Dr Balaji Ganeshan will be presenting at the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (\"RSNA 2017\") taking place from 26 November to 1 December 2017 in Chicago (IL), USA.\n \nThe details for the oral presentation on the study undertaken at the Institute of Nuclear Medicine, University College London, UK are as follows:\n \nDate and session time: Wednesday 29 November at 15:00 - 16:00 CST\nTitle: Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults with Neuro-Endocrine Cancers Treated with 177Lu-DOTATATE\nAbstract number: SSM13-06\nSession: Molecular Imaging (Analysis and Quantification)\nRoom: S504C\nPresenter: Balaji Ganeshan, PhD\n \nTwo additional papers co-authored by Dr Balaji Ganeshan will be presented at RSNA 2017; one by Seoul National University and University College London focused on liver cancer (abstract SSK07-05), and one by Cambridge University, the University of Rome and University College London focused on ischemic stroke (abstract SSQ15-02). Overall, RSNA 2017 is expected to include at least 18 scientific paper presentations featuring TexRAD® Computed Tomography Texture Analysis (CTTA) and Magnetic Resonance Texture Analysis (MRTA), many of which have won awards in this year's RSNA categories. Further information can be found at https://rsna2017.rsna.org/program.\n \nDr Balaji Ganeshan, Director of New Business at Feedback plc, said: \"RSNA is the premier global event for radiologists and the increasing focus on our TexRAD® technology is encouraging. As seen in previous years, our renowned customers will highlight multiple TexRAD® presentations across various disease indications, further emphasising the significance of our technology across the healthcare industry. We look forward to discussing TexRAD® with this year's RSNA delegates.\"\n \nTexRAD® is the Company's patented quantitative image texture analysis technology for diagnostic radiological scans. The technology has the potent...